Autonomix Medical says two transvascular technology abstracts accepted for CIRSE 2026 posters
AMIX•Two abstracts accepted for CIRSE 2026 poster presentations
Autonomix Medical disclosed acceptance of two clinical research abstracts for poster presentation at the CIRSE 2026 congress.
Results have not been presented yet; posters are scheduled for September 5-9, 2026, in Copenhagen.
One study reports long-term findings suggesting transvascular RF denervation may help mitigate pain in pancreatic adenocarcinoma.
The second presentation outlines use of the same platform for precision-guided mapping of neural structures to support nerve-targeted interventions.
